Literature DB >> 9601508

Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence.

K Jnaoui1, T Michiels.   

Abstract

Persistent strains of Theiler's virus, a murine picornavirus, produce a life-long infection of the central nervous system of the mouse and induce a chronic demyelinating disease. Strain DA1, a molecular clone of such a persistent strain, produces a prominent cytopathic effect in BHK-21 cells but is less efficient at infecting L929 cells. We cloned the cDNA of a derivative of virus DA1, adapted to promote a rapid cytopathic effect in L929 cells. Adaptation of the new variant (named KJ6) to L929 cells correlated with an enhanced viral entry rather than with an increased replication rate of the genome. Mutations responsible for L929 cells adaptation occurred in amino acids exposed at the surface of the capsid, in the CD loop of VP1 (100-102) and in the EF loop of VP2 (162-171-173), suggesting that these residues could be involved in receptor recognition. These two clusters of amino acids are precisely known to be part of neutralization epitopes. They also differentiate persistent from neurovirulent strains of Theiler's virus. Adaptation of the virus to L929 cells was accompanied by attenuation of its virulence for the mouse. Taken together, these data suggest a close relationship between receptor binding, virus neutralization, and virus phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9601508     DOI: 10.1006/viro.1998.9134

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

1.  Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains.

Authors:  K Jnaoui; T Michiels
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus.

Authors:  L Zhou; Y Luo; Y Wu; J Tsao; M Luo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins.

Authors:  Sophie Delhaye; Vincent van Pesch; Thomas Michiels
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  The leader protein of cardioviruses inhibits stress granule assembly.

Authors:  Fabian Borghese; Thomas Michiels
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

5.  Theiler's virus L* protein is targeted to the mitochondrial outer membrane.

Authors:  Frédéric Sorgeloos; Didier Vertommen; Mark H Rider; Thomas Michiels
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

6.  Inefficient type I interferon-mediated antiviral protection of primary mouse neurons is associated with the lack of apolipoprotein l9 expression.

Authors:  Marguerite Kreit; Sophie Paul; Laurent Knoops; Aurélie De Cock; Frédéric Sorgeloos; Thomas Michiels
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

7.  The Leader Protein of Theiler's Virus Prevents the Activation of PKR.

Authors:  Fabian Borghese; Frédéric Sorgeloos; Teresa Cesaro; Thomas Michiels
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

8.  The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view.

Authors:  E A Hewat; E Neumann; J F Conway; R Moser; B Ronacher; T C Marlovits; D Blaas
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

9.  Random mutagenesis defines a domain of Theiler's virus leader protein that is essential for antagonism of nucleocytoplasmic trafficking and cytokine gene expression.

Authors:  Céline Ricour; Fabian Borghese; Frédéric Sorgeloos; Stanleyson V Hato; Frank J M van Kuppeveld; Thomas Michiels
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

10.  Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections.

Authors:  Charles Y Chiu; Alexander L Greninger; Kimberly Kanada; Thomas Kwok; Kael F Fischer; Charles Runckel; Janice K Louie; Carol A Glaser; Shigeo Yagi; David P Schnurr; Tom D Haggerty; Julie Parsonnet; Don Ganem; Joseph L DeRisi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.